Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Cash & Current Investments (2019 - 2025)

Historic Cash & Current Investments for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to $306.7 million.

  • Outset Medical's Cash & Current Investments rose 9330.12% to $306.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $306.7 million, marking a year-over-year increase of 9330.12%. This contributed to the annual value of $306.7 million for FY2025, which is 9330.12% up from last year.
  • According to the latest figures from Q4 2025, Outset Medical's Cash & Current Investments is $306.7 million, which was up 9330.12% from $324.2 million recorded in Q3 2025.
  • Outset Medical's 5-year Cash & Current Investments high stood at $440.4 million for Q1 2022, and its period low was $158.7 million during Q4 2024.
  • Moreover, its 5-year median value for Cash & Current Investments was $269.8 million (2021), whereas its average is $277.4 million.
  • In the last 5 years, Outset Medical's Cash & Current Investments soared by 17927.34% in 2021 and then tumbled by 4341.48% in 2023.
  • Over the past 5 years, Outset Medical's Cash & Current Investments (Quarter) stood at $372.8 million in 2021, then fell by 21.99% to $290.8 million in 2022, then fell by 28.94% to $206.7 million in 2023, then decreased by 23.21% to $158.7 million in 2024, then soared by 93.3% to $306.7 million in 2025.
  • Its Cash & Current Investments was $306.7 million in Q4 2025, compared to $324.2 million in Q3 2025 and $331.9 million in Q2 2025.